Cambridge Cognition Holdings PLC Notice of Results (6069X)
23 February 2017 - 6:02PM
UK Regulatory
TIDMCOG
RNS Number : 6069X
Cambridge Cognition Holdings PLC
23 February 2017
23 February 2017
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Notice of Results
The neuroscience digital health company Cambridge Cognition
Holdings PLC (Cambridge, UK - LSE: COG) will be reporting its
preliminary results for the twelve months ended 31 December 2016 on
Wednesday 29 March 2017.
Enquiries
Cambridge Cognition Holdings PLC
Steven Powell, Chief Executive Tel: 01223 810
Officer 700
Noah Konig, Director of Marketing press@camcog.com
and Communications
finnCap Ltd (NOMAD and Joint Broker) Tel: 020 7220
Geoff Nash / Simon Hicks 0500
Alice Lane (Corporate Finance)
(Corporate Broking)
Dowgate Capital Stockbrokers Limited Tel: 01293 517
David Poutney / James Serjeant 744
Notes to editors
About Cambridge Cognition Holdings PLC
Cambridge Cognition is a neuroscience digital health company
specialising in the precise measurement of clinical outcomes in
neurological disorders. The Company develops and markets validated
near patient assessment products using cognition as a biomarker to
improve understanding, diagnosis and treatment in brain health
worldwide.
Partners include the world's leading drug development companies,
academic institutions and public-private health organisations.
www.cambridgecognition.com @CANTABconnect press@camcog.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBIGDDSDDBGRD
(END) Dow Jones Newswires
February 23, 2017 02:02 ET (07:02 GMT)
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Apr 2024 to May 2024
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From May 2023 to May 2024